Evixapodlin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Evixapodlin, covering 2022-08-10 to 2022-08-10. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors [Phase 1]